Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04487041 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tfh Dysfunction in HIV and Aging

StatusActive, Not Recruiting
PhasePhase 4
Started2020-10-30
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 10 months later Jun 30, 2026 → Apr 30, 2027
See other at-risk trials from University of Miami

Amendment history

2026-07-16
critical
Study Status v9
Primary completion pushed: 2026-06-30 → 2027-04-30
Completion pushed: 2026-12-30 → 2027-12-30
2026-05-18
notable
Recruiting→Active, Not Recruiting Study Status, Contacts/Locations v8
Trial statusRecruiting→Active, Not Recruiting
Study sitesdetails revised at 1 of 1 site
2025-05-28
minor
Study Status v7
Primary completion date2025-09-30→2026-06-30
Completion date2025-09-30→2026-12-30
2024-09-06
minor
2 amendments v5-v6
2 re-verifications since 2023-09-22, no change to tracked fields
2022-10-17
minor
Study Status v4
Primary completion date2023-09-30→2025-09-30
Completion date2023-09-30→2025-09-30
Show 3 earlier versions
2021-11-10
minor
Study Status, Arms and Interventions v3
Re-verified, no change to tracked fields
2020-12-02
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2020-11-01→confirmed 2020-10-30
Study sitesdetails revised at 1 of 1 site
2020-09-29
minor
Study Status v1
Start date2020-10-01→2020-11-01
2020-07-22
minor
Original filing
The purpose of this research is to evaluate blood samples from HIV infected and non-HIV infected people to understand how aging and HIV infection affect the immune responses (body defenses against infection) to the flu vaccine.
Trial Details
NCT Number NCT04487041
Lead Sponsor University of Miami
Conditions Human Influenza
Enrollment 400 participants
Start Date 2020-10-30
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-17